Skip to main content

Aditxt, Inc.

ADTX
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001726711

No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Aditxt, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ADTX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders2816−12
Shares2.75M289.7K−2.46M (−89.5%)
Value$392.5K$983.2K+$590.7K (+150.5%)

New holders (3)

Institutions that held Aditxt, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ADTX in Q3 2022
InstitutionSharesValue% of portfolio
Sabby Management, LLC173,409$588.0K1.27%
Bank of New York Mellon Corp34,968$119.0K0.00%
Royal Bank of Canada1$00.00%

Sold out (15)

Institutions that held Aditxt, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ADTX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Vanguard Group Inc1,258,447$180.0K
Virtu Financial LLC495,665$71.0K
Inspire Advisors, LLC226,883$32.0K
Geode Capital Management, LLC217,991$31.0K
HRT Financial LP48,105$6.00K
Warberg Asset Management LLC39,900$6.00K
Alpha Cubed Investments, LLC33,050$5.00K
Northern Trust Corp19,163$3.00K
Millennium Management LLC19,060$3.00K
Citigroup Inc10,666$2.00K
Susquehanna International Group, LLP11,242$2.00K
Two Sigma Securities, LLC12,170$2.00K
Tiedemann Advisors, LLC10,000$1.00K
Simplex Trading, LLC82$0
Captrust Financial Advisors600$0